Company / AR per Share
AMICUS THERAPEUTICS, INC. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.39
FY2025
5-year range
$0.20 / $0.39
FY2021-FY2025
Trend
+12.0%
vs FY2024
Sector context
#73 of 113
Health Care
What the data says
At $0.39, AMICUS THERAPEUTICS, INC.'s ar per share ranks #73 of 113 in the Health Care sector. AR per Share has increased for 9 consecutive years, from $0.01 in FY2016 to $0.39 in FY2025.
Based on SEC 10-K filings.
0.39 in FY2025 with a 5-year CAGR of +16.3%.
Improved from $0.31 to $0.39 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- +16.3%
- 10-Year CAGR
- -
Sector benchmark
#73 of 113 in Health CareTop 65% of 113This company $0.39 Sector average $28.83
▼
-98.7% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s ar per share has grown for 9 consecutive years.
- In FY2025, ar per share increased 12.0% year-over-year.
- Ranks #73 out of 113 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.39 | +12.0% |
| FY2024 | $0.34 | +10.5% |
| FY2023 | $0.31 | +31.3% |
| FY2022 | $0.24 | +18.1% |
| FY2021 | $0.20 | +10.9% |
| FY2020 | $0.18 | +30.9% |
| FY2019 | $0.14 | +17.1% |
| FY2018 | $0.12 | +78.2% |
| FY2017 | $0.07 | +535.9% |
| FY2016 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026